Hepatitis B Virus Hbv clinical trials

Explore recruiting hepatitis b virus hbv clinical trials.

Recruiting hepatitis b virus hbv studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Hepatitis B Virus Hbv trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Pomalidomide in people with chronic hepatitis B virus (HBV) infection: Safety and immune-enhancing effects (The PIPPI Study)

Denmark

Phase I and Phase II (Integrated)- Other EU CTIS Study details

A Platform Study Evaluating the Efficacy and Safety of Investigational Therapies in Participants with Chronic Hepatitis B Infection (PREVAIL)

France, Romania

Therapeutic exploratory (Phase II) EU CTIS Study details

A Phase 1/2a, Randomized, Placebo-Controlled Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Antiviral Activity of BJT-778 in Healthy Volunteers and in Subjects with Chronic Hepatitis B Infection, Including Subjects with Chronic Hepatitis D Infection

Bulgaria, Romania, France

Phase I and Phase II (Integrated)- Other EU CTIS Study details

A Multicenter, Randomized, Double-Blind, Placebo-controlled Study to Assess the Efficacy and Safety of Treatment with Bepirovirsen in Participants living with Human Immunodeficiency Virus and Chronic Hepatitis B Virus Infection on Antiretroviral Treatment

France, Spain, Italy

Therapeutic exploratory (Phase II) EU CTIS Study details

ANRS HB07 IP-Cure-B proof of concept (PoC) clinical trial. Educating the liver immune environment through TLR8 stimulation followed by NUC discontinuation.

Italy, Spain, Germany, France

Therapeutic exploratory (Phase II) EU CTIS Study details

A single-arm phase II study of cetuximab plus platinum and taxane-based chemotherapy followed by AVElumab and Cetuximab as first-line therapy for recurrent/metastatic (R/M) head and neck squamous cell carcinoma (HNSCC) patients with PD-L1 combined positive score (CPS)≥1≤19: the immunotherapy.

Italy

Therapeutic exploratory (Phase II) EU CTIS Study details

Hepatitis B Virus Hbv trials by city

Hepatitis B Virus Hbv in Toronto Hepatitis B Virus Hbv in Vancouver Hepatitis B Virus Hbv in Montreal Hepatitis B Virus Hbv in Calgary Hepatitis B Virus Hbv in Edmonton Hepatitis B Virus Hbv in Ottawa Hepatitis B Virus Hbv in Winnipeg Hepatitis B Virus Hbv in Quebec City Hepatitis B Virus Hbv in Hamilton Hepatitis B Virus Hbv in Kitchener Hepatitis B Virus Hbv in London Hepatitis B Virus Hbv in Halifax Hepatitis B Virus Hbv in New York Hepatitis B Virus Hbv in Los Angeles Hepatitis B Virus Hbv in Chicago Hepatitis B Virus Hbv in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease